Defatted bovine milk fat globule membrane inhibits association of enterohaemorrhagic Escherichia coli O157:H7 with human HT-29 cells

International Dairy Journal

Volumn 59, Issue , 2016, Pages 36-43

  Ross, Sarah A ^a,b   Lane, Jonathan A ^a   Kilcoyne, Michelle ^b   Joshi, Lokesh ^b   Hickey, Rita M ^a  

^a TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CYTOLOGY; MAMMALS; OILS AND FATS; POLYSACCHARIDES;

ADVERSE HEALTH EFFECTS; ANTIBIOTIC TREATMENT; BOVINE MILK; CONCENTRATION-DEPENDENT; E.COLI O157:H7; ESCHERICHIA COLI O157:H7; HT-29 CELLS; NEW APPROACHES;

ESCHERICHIA COLI;

EID: 84962235596     PISSN: 09586946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idairyj.2016.03.001     Document Type: Article

References (64)

1. Bardiau M., Szalo M., Mainil J.G. Initial adherence of EPEC, EHEC and VTEC to host cells. Veterinary Research 2010, 41:57.
2. CDC Multistate outbreak of Shiga toxin-producing Escherichia coli O157:H7 infections linked to organic spinach and spring mix blend 2013, Centers for Disease Control, Atlanta, GA, USA.
3. CDC. Investigation of multistate outbreak of E. coli O157:H7 infections 2008, Centers for Disease Control, Atlanta, GA, USA.
4. Coppa G.V., Zampini L., Galeazzi T., Facinelli B., Ferrante L., Capretti R., et al. Human milk oligosaccharides inhibit the adhesion to Caco-2 cells of diarrheal pathogens: Escherichia coli, Vibrio cholerae, and Salmonella fyris. Pediatric Research 2006, 59:377-382.
5. Cravioto A., Tello A., Villafan H., Ruiz J., Delvedovo S., Neeser J.R. Inhibition of localized adhesion of enteropathogenic Escherichia coli to HEp2 cells by immunoglobulin and oligosaccharide fractions of human colostrum and breast milk. Journal of Infectious Diseases 1991, 163:1247-1255.
6. Croxen M.A., Law R.J., Scholz R., Keeney K.M., Wlodarska M., Finlay B.B. Recent advances in understanding enteric pathogenic Escherichia coli. Clinical Microbiology Reviews 2013, 26:822-880.
7. DeVinney R., Puente J.L., Gauthier A., Goosney D., Finlay B.B. Enterohaemorrhagic and enteropathogenic Escherichia coli use a different Tir-based mechanism for pedestal formation. Molecular Microbiology 2001, 41:1445-1458.
8. Duffy G., Butler F., Cummins E., O'Brien S., Nally P., Carney E., et al. E. coli O157:H7 in beef burgers produced in the Republic of Ireland: A quantitative microbial risk assessment. Scribblestown 2006, Ashtown Food Research Centre, Dublin, Ireland: Teagasc.
9. Erdem A.L., Avelino F., Xicohtencatl-Cortes J., Girón J.A. Host protein binding and adhesive properties of H6 and H7 flagella of attaching and effacing Escherichia coli. Journal of Bacteriology 2007, 189:7426-7435.
10. Feng P. Pathogenic Escherichia coli group. Bad bug book. Handbook of foodborne pathogenic microorganisms and natural toxins 2012, 72-81. Food and Drug Administration, Silver Spring, MD, USA. K.A. Lampel, S. Al-Khaldi, S.M. Cahill (Eds.).
11. Foster J.W. Escherichia coli acid resistance: tales of an amateur acidophile. Nature Reviews Microbiology 2004, 2:898-907.
12. Frenzen P.D., Drake A., Angulo F.J., Group E.I.P.F.W. Economic cost of illness due to Escherichia coli O157 infections in the United States. Journal of Food Protection 2005, 68:2623-2630.
13. Gallier S., Cui J., Olson T.D., Rutherfurd S.M., Ye A., Moughan P.J., et al. In vivo digestion of bovine milk fat globules: effect of processing and interfacial structural changes. I. Gastric digestion. Food Chemistry 2013, 141:3273-3281.
14. Gallier S., Zhu X.Q., Rutherfurd S.M., Ye A., Moughan P.J., Singh H. In vivo digestion of bovine milk fat globules: effect of processing and interfacial structural changes. II. Upper digestive tract digestion. Food Chemistry 2013, 141:3215-3223.
15. Gould L.H., Demma L., Jones T.F., Hurd S., Vugia D.J., Smith K., et al. Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006. Clinical Infectious Diseases 2009, 49:1480-1485.
16. Hakkarainen J., Toivanen M., Leinonen A., Frängsmyr L., Strömberg N., Lapinjoki S., et al. Human and bovine milk oligosaccharides inhibit Neisseria meningitidis pili attachment in vitro. Journal of Nutrition 2005, 135:2445-2448.
17. Horemans T., Kerstens M., Clais S., Struijs K., van den Abbeele P., Van Assche T., et al. Evaluation of the anti-adhesive effect of milk fat globule membrane glycoproteins on Helicobacter pylori in the human NCI-N87 cell line and C57BL/6 mouse model. Helicobacter 2012, 17:312-318.
18. IDF Skimmed milk, whey and buttermilk - Determination of fat content - Gravimetric method, ISO 7208. IDF standard 22. Brussels 2008, International Dairy Federation, Belgium.
19. Idota T., Kawakami H. Inhibitory effects of milk ganglioside on the adhesion of Escherichia coli to human intestinal carcinoma cells. Bioscience Biotechnology and Biochemistry 1995, 59:69-72.
20. Inagaki M., Muranishi H., Yamada K., Kakehi K., Uchida K., Suzuki T., et al. Bovine κ-casein inhibits human rotavirus (HRV) infection via direct binding of glycans to HRV. Journal of Dairy Science 2014, 97:2653-2661.
21. Inagaki M., Nagai S., Yabe T., Nagaoka S., Minamoto N., Takahashi T., et al. The bovine lactophorin C-terminal fragment and PAS6/7 were both potent in the inhibition of human rotavirus replication in cultured epithelial cells and the prevention of experimental gastroenteritis. Bioscience Biotechnology and Biochemistry 2010, 74:1386-1390.
22. Ito O., Kamata S., Hayashi M., Ushiyama K. Milk fat globule membrane substances inhibit mouse intestinal β-glucuronidase. Journal of Food Science 1993, 58:753-755.
23. Kvistgaard A.S., Pallesen L.T., Arias C.F., López S., Petersen T.E., Heegaard C.W., et al. Inhibitory effects of human and bovine milk constituents on rotavirus infections. Journal of Dairy Science 2004, 87:4088-4096.
24. Lane J.A., Marino K., Naughton J., Kavanaugh D., Clyne M., Carrington S.D., et al. Anti-infective bovine colostrum oligosaccharides: Campylobacter jejuni as a case study. International Journal of Food Microbiology 2012, 157:182-188.
25. Le T.T., Van Camp J., Rombaut R., van Leeckwyck F., Dewettinck K. Effect of washing conditions on the recovery of milk fat globule membrane proteins during the isolation of milk fat globule membrane from milk. Journal of Dairy Science 2009, 92:3592-3603.
26. Le T.T., Van de Wiele T., Do T.N.H., Debyser G., Struijs K., Devreese B., et al. Stability of milk fat globule membrane proteins toward human enzymatic gastrointestinal digestion. Journal of Dairy Science 2012, 95:2307-2318.
27. Liu B., Yu Z., Chen C., Kling D.E., Newburg D.S. Human milk mucin 1 and mucin 4 inhibit Salmonella enterica Serovar Typhimurium invasion of human intestinal epithelial cells in vitro. Journal of Nutrition 2012, 142:1504-1509.
28. Mahajan A., Currie C.G., Mackie S., Tree J., McAteer S., McKendrick I., et al. An investigation of the expression and adhesin function of H7 flagella in the interaction of Escherichia coli O157:H7 with bovine intestinal epithelium. Cellular Microbiology 2009, 11:121-137.
29. Manthey C.F., Autran C.A., Eckmann L., Bode L. Human milk oligosaccharides protect against enteropathogenic Escherichia coli attachment in vitro and EPEC colonization in suckling mice. Journal of Pediatric Gastroenterology and Nutrition 2014, 58:165-168.
30. Marotta M., Ryan J.T., Hickey R.M. The predominant milk oligosaccharide 6'-sialyllactose reduces the internalisation of Pseudomonas aeruginosa in human pneumocytes. Journal of Functional Foods 2014, 6:367-373.
31. Matrosovich M.N., Gambaryan A.S., Tuzikov A.B., Byramova N.E., Mochalova L.V., Golbraikh A.A., et al. Probing of the receptor-binding sites of the H1 and H3 Influenza A and Influenza B virus hemagglutinins by synthetic and natural sialosides. Virology 1993, 196:111-121.
32. Mead P.S., Slutsker L., Dietz V., McCaig L.F., Bresee J.S., Shapiro C., et al. Food-related illness and death in the United States. Emerging Infectious Diseases 1999, 5:607.
33. Mellies J.L., Barron A.M., Carmona A.M. Enteropathogenic and enterohemorrhagic Escherichia coli virulence gene regulation. Infection and Immunity 2007, 75:4199-4210.
34. Morrow A.L., Ruiz-Palacios G.M., Altaye M., Jiang X., Guerrero M.L., Meinzen-Derr J.K., et al. Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants. Journal of Pediatrics 2004, 145:297-303.
35. Mouricout M., Petit J.M., Carias J.R., Julien R. Glycoprotein glycans that inhibit adhesion of Escherichia coli mediated by K99 fimbriae - treatment of experimental colibacillosis. Infection and Immunity 1990, 58:98-106.
36. Mysore J.V., Wigginton T., Simon P.M., Zopf D., Heman-Ackah L.M., Dubois A. Treatment of Helicobacter pylori infection in rhesus monkeys using a novel antiadhesion compound. Gastroenterology 1999, 117:1316-1325.
37. Ochoa T.J., Barletta F., Contreras C., Mercado E. New insights into the epidemiology of enteropathogenic Escherichia coli infection. Transactions of the Royal Society of Tropical Medicine and Hygiene 2008, 102:852-856.
38. Ofek I., Hasty D.L., Sharon N. Anti-adhesion therapy of bacterial diseases: prospects and problems. FEMS Immunology and Medical Microbiology 2003, 38:181-191.
39. Parker P., Sando L., Pearson R., Kongsuwan K., Tellam R.L., Smith S. Bovine Muc1 inhibits binding of enteric bacteria to Caco-2 cells. Glycoconjugate Journal 2010, 27:89-97.
40. Pereira A.L., Giugliano L.G. Adhesion of diarrheagenic Escherichia coli and inhibition by glycocompounds engaged in the mucosal innate immunity. Biology 2013, 2:810-831.
41. Rombaut R., Dejonckheere V., Dewettinck K. Filtration of milk fat globule membrane fragments from acid buttermilk cheese whey. Journal of Dairy Science 2007, 90:1662-1673.
42. Ross S.A., Lane J.A., Kilcoyne M., Joshi L., Hickey R.M. The milk fat globule membrane: a potential source of health promoting glycans. Biotechnology of bioactive compounds: Sources and applications 2015, 631-668. Wiley Blackwell, West Sussex, UK. V.K. Gupta, M.G. Tuohy, A. O'Donovan, M. Lohani (Eds.).
43. Sajjan S.U., Forstner J.F. Characteristics of binding of Escherichia coli serotype O157:H7 strain CL-49 to purified intestinal mucin. Infection and Immunity 1990, 58:860-867.
44. Salcedo J., Barbera R., Matencio E., Alegria A., Lagarda M.J. Gangliosides and sialic acid effects upon newborn pathogenic bacteria adhesion: an in vitro study. Food Chemistry 2013, 136:726-734.
45. Sang W.K., Saidi S.M., Yamamoto H., Ezaki T., Iida T., Yoh M., et al. Haemorhagic colitis due to Escherichia coli O157:H7 in Kenya. Journal of Tropical Pediatrics 1996, 42:118-119.
46. Scaletsky I., Milani S.R., Trabulsi L.R., Travassos L.R. Isolation and characterization of the localized adherence factor of enteropathogenic Escherichia coli. Infection and Immunity 1988, 56:2979-2983.
47. Scallan E., Hoekstra R., Mahon B., Jones T., Griffin P. An assessment of the human health impact of seven leading foodborne pathogens in the United States using disability adjusted life years. Epidemiology and Infection 2015, 143:2795-2804.
48. Schlumberger M.C., Hardt W.-D. Salmonella type III secretion effectors: pulling the host cell's strings. Current Opinion in Microbiology 2006, 9:46-54.
49. Schroten H., Hanisch F.G., Plogmann R., Hacker J., Uhlenbruck G., Nobis-Bosch R., et al. Inhibition of adhesion of S-fimbriated Escherichia coli to buccal epithelial cells by human milk fat globule membrane components: a novel aspect of the protective function of mucins in the nonimmunoglobulin fraction. Infection and Immunity 1992, 60:2893-2899.
50. Sharon N., Ofek I. Safe as mother's milk: carbohydrates as future anti-adhesion drugs for bacterial diseases. Glycoconjugate Journal 2000, 17:659-664.
51. Shida K., Takamizawa K., Nagaoka M., Kushiro A., Osawa T., Tsuji T. Enterotoxin-binding glycoproteins in a proteose peptone fraction of heated bovine milk. Journal of Dairy Science 1994, 77:930-939.
52. Sprong C.R., Hulstein M.F.E., Lambers T.T., van der Meer R. Sweet buttermilk intake reduces colonisation and translocation of Listeria monocytogenes in rats by inhibiting mucosal pathogen adherence. British Journal of Nutrition 2012, 108:2026-2033.
53. Strachan N.J.C., Doyle M.P., Kasuga F., Rotariu O., Ogden I.D. Dose response modelling of Escherichia coli O157 incorporating data from foodborne and environmental outbreaks. International Journal of Food Microbiology 2005, 103:35-47.
54. Struijs K., Van de Wiele T., Le T.T., Debyser G., Dewettinck K., Devreese B., et al. Milk fat globule membrane glycoproteins prevent adhesion of the colonic microbiota and result in increased bacterial butyrate production. International Dairy Journal 2013, 32:99-109.
55. Symonds J. Haemorrhagic colitis and Escherichia coli O157-a pathogen unmasked. British Medical Journal 1988, 296:875-876.
56. Tellez A., Corredig M., Guri A., Zanabria R., Griffiths M.W., Delcenserie V. Bovine milk fat globule membrane affects virulence expression in Escherichia coli O157:H7. Journal of Dairy Science 2012, 87:6313-6319.
57. Teneberg S., Ångström J., Ljungh Å. Carbohydrate recognition by enterohemorrhagic Escherichia coli: characterization of a novel glycosphingolipid from cat small intestine. Glycobiology 2004, 14:187-196.
58. Trabulsi L.R., Keller R., Tardelli Gomes T. Typical and atypical enteropathogenic Escherichia coli. Emerging Infectious Diseases 2002, 8:508-513.
59. Vanmaele R.P., Finlayson M.C., Armstrong G.D. Effect of enteropathogenic Escherichia coli on adherent properties of Chinese hamster ovary cells. Infection and Immunity 1995, 63:191-198.
60. Wang X., Hirmo S., Willen R., Wadstrom T. Inhibition of Helicobacter pylori infection by bovine milk glycoconjugates in a BALB/cA mouse model. Journal of Medical Microbiology 2001, 50:430-435.
61. Wong C.S., Mooney J.C., Brandt J.R., Staples A.O., Jelacic S., Boster D.R., et al. Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis. Clinical Infectious Diseases 2012, 55:33-41.
62. Ye A., Singh H., Taylor M.W., Anema S. Characterization of protein components of natural and heat-treated milk fat globule membranes. International Dairy Journal 2002, 12:393-402.
63. Ye J., Song L., Liu Y., Pan Q., Zhong X., Li S., et al. Core 2 mucin-type O-glycan is related to EPEC and EHEC O157:H7 adherence to human colon carcinoma HT-29 epithelial cells. Digestive Diseases and Sciences 2015, 60:1977-1990.
64. Yolken R.H., Peterson J.A., Vonderfecht S.L., Fouts E.T., Midthun K., Newburg D.S. Human-milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis. Journal of Clinical Investigation 1992, 90:1984-1991.